NEW ORLEANS -- In an interview at the Society of Nuclear Medicine and Molecular Imaging annual meeting, Phillip Kuo, MD, PhD, of the City of Hope in Duarte, CA, discussed new appropriate use criteria for amyloid and tau PET imaging in Alzheimer’s disease patients.
Video from SNMMI: Phillip Kuo on new Alzheimer’s disease imaging guidelines
Latest in Molecular Imaging
PET/CT detects bone involvement in patients with lymphoma
December 19, 2025
Mediso highlights first 7T PET/MRI scanner installed in U.S.
December 19, 2025
AtomVie signs supply agreement with Ionetix for Ac-225 development
December 18, 2025



















